International Expert Consensus on Switching Platelet P2Y
            <sub>12</sub>
            Receptor–Inhibiting Therapies

J. Angiolillo, Dominick; Rollini, Fabiana; F. Storey, Robert; L. Bhatt, Deepak; James, Stefan; J. Schneider, David; Sibbing, Dirk; Y.F. So, Derek; Trenk, Dietmar; Alexopoulos, Dimitrios; A. Gurbel, Paul; Hochholzer, Willibald; De Luca, Leonardo; Bonello, Laurent; Aradi, Daniel; Cuisset, Thomas; S. Tantry, Udaya; Y. Wang, Tracy; Valgimigli, Marco; Waksman, Ron; Mehran, Roxana; Montalescot, Gilles; Franchi, Francesco; J. Price, Matthew

doi:10.1161/circulationaha.117.031164

Public

International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies

Shared by NobleBlocks on Nov 14, 2017 • 12:00 AM UTC

Authors:

Dominick J. Angiolillo

Fabiana Rollini

Robert F. Storey

Abstract

Dual antiplatelet therapy with aspirin and a P2Y 12 inhibitor is the treatment of choice for the prevention of atherothrombotic events in patients with acute coronary syndromes and for those undergoing percutaneous coronary interventions. The availability of different oral P2Y 12 inhibitors (clopido...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!